ZA975197B - Intermediates for oligonucleotides. - Google Patents

Intermediates for oligonucleotides.

Info

Publication number
ZA975197B
ZA975197B ZA9705197A ZA975197A ZA975197B ZA 975197 B ZA975197 B ZA 975197B ZA 9705197 A ZA9705197 A ZA 9705197A ZA 975197 A ZA975197 A ZA 975197A ZA 975197 B ZA975197 B ZA 975197B
Authority
ZA
South Africa
Prior art keywords
group
hydrogen
formula
nucleoside
nuc
Prior art date
Application number
ZA9705197A
Other languages
English (en)
Inventor
Stephen Paul Collingwood
Heinz Ernst Moser
Karl-Heinz Altmann
Mark Edward Douglas
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA975197B publication Critical patent/ZA975197B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA9705197A 1996-06-13 1997-06-12 Intermediates for oligonucleotides. ZA975197B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612600.8A GB9612600D0 (en) 1996-06-13 1996-06-13 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA975197B true ZA975197B (en) 1997-12-15

Family

ID=10795396

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705197A ZA975197B (en) 1996-06-13 1997-06-12 Intermediates for oligonucleotides.

Country Status (12)

Country Link
US (1) US6329519B1 (fr)
EP (1) EP0906327B1 (fr)
JP (1) JP2000512288A (fr)
CN (1) CN1221423A (fr)
AT (1) ATE210675T1 (fr)
AU (1) AU2971997A (fr)
BR (1) BR9709791A (fr)
CA (1) CA2257453A1 (fr)
DE (1) DE69709098T2 (fr)
GB (1) GB9612600D0 (fr)
WO (1) WO1997047636A2 (fr)
ZA (1) ZA975197B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44779E1 (en) 1997-03-07 2014-02-25 Santaris Pharma A/S Bicyclonucleoside and oligonucleotide analogues
JP3756313B2 (ja) * 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6770748B2 (en) 1997-03-07 2004-08-03 Takeshi Imanishi Bicyclonucleoside and oligonucleotide analogue
US7030230B2 (en) 2002-10-25 2006-04-18 Isis Pharmaceuticals, Inc. Process of purifying phosphoramidites
EP2708541B1 (fr) 2003-11-13 2015-01-28 Isis Pharmaceuticals, Inc. Dérivés de 5, 6-dihydroxy-isoindole en tant que lieurs pour une synthèse en phase solide d'oligomères

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307744A1 (de) 1983-03-04 1984-09-06 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig 2'-desoxy-3'-phosphonylmethyl-nucleoside
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
DE4037363A1 (de) 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
US5658731A (en) * 1990-04-09 1997-08-19 Europaisches Laboratorium Fur Molekularbiologie 2'-O-alkylnucleotides as well as polymers which contain such nucleotides
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
GB9304618D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
GB9311682D0 (en) 1993-06-05 1993-07-21 Ciba Geigy Ag Chemical compounds
GB9417746D0 (en) 1994-09-03 1994-10-19 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
EP0906327A2 (fr) 1999-04-07
CN1221423A (zh) 1999-06-30
AU2971997A (en) 1998-01-07
EP0906327B1 (fr) 2001-12-12
JP2000512288A (ja) 2000-09-19
ATE210675T1 (de) 2001-12-15
US6329519B1 (en) 2001-12-11
WO1997047636A3 (fr) 1998-02-12
BR9709791A (pt) 1999-08-10
GB9612600D0 (en) 1996-08-21
DE69709098D1 (de) 2002-01-24
WO1997047636A2 (fr) 1997-12-18
DE69709098T2 (de) 2002-09-05
CA2257453A1 (fr) 1997-12-18

Similar Documents

Publication Publication Date Title
IL117848A0 (en) Novel compounds a process for their production and pharmacetical compositions containing same
PT915866E (pt) Processo aperfeicoado para a sintese de esteres protegidos do acido (s)-3,4-di-hidroxibutirico
ATE188216T1 (de) Therapeutische mittel für die parkinsonsche krankheit
GB2346879A (en) Preparation of 3-substituted adenines and imidazo pyridines
NZ298296A (en) Imidazo[4,5-c]quinoline amines; medicaments to induce interferon biosynthesis
ATE266013T1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
HUP9902576A1 (hu) Új eritromicinszármazékok, eljárás előállításukra és alkalmazásuk gyógyászati készítményekben
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
DE69028610D1 (de) Chirale 1,5-diiodo-2-methoxy oder benzyloxy Zwischenprodukte
ZA975197B (en) Intermediates for oligonucleotides.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ES8802302A1 (es) Procedimiento para la obtencion de 1-aril-4-nitropirazoles.
SE8501988D0 (sv) Iminothiazolidine derivatives
IL104478A (en) N-5-protected 2,5-diamino-4, 6-dichloropyrimidines and processes for their preparation
HK1019063A1 (en) Dibenzo-oxazepine and- dioxepine derivatives and their use as anti-tumor agents
GB9906328D0 (en) 2-Substituted RNA preparation
NZ334308A (en) Nodulosporic acid derivatives that are isolated from Nodulisporium sp. MF-5954 which are acaricidal, antiparasitic and anthelmintic agents
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
ID19038A (id) Turunan feniletanolaminotetralinkarboksamida
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
YU37902A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova
TH22634A (th) " เบนซอกซาโซลิล และเบนโซไธอะโซลิลออกซาโซลิดิโนน "
MX9708083A (es) Inmunopotenciacion con inosina monofostato resistente a la 5'-nucleotidasa derivados y sus usos.